The Clinical and Molecular Rersponse of Pyoderma Gangrenosum to Interleukin 23 Blockade: results from a proof-of-concept open-label clinical trial
Ontology highlight
ABSTRACT: Open Label Clinical Trial
ORGANISM(S): Homo sapiens
PROVIDER: GSE271627 | GEO | 2024/07/09
REPOSITORIES: GEO
ACCESS DATA
